Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 17 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Boukovinas, Ioannis [Clear All Filters]
Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO..
Ann Gastroenterol. 29(1), 18-23.
(2016). Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)..
Ann Gastroenterol. 29(4), 390-416.
(2016). Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO..
Ann Gastroenterol. 29(1), 3-17.
(2016).
(2016).
(2020). The development of bronchoscopy in China: a national cross-sectional study..
J Cancer. 11(19), 5547-5555.
(2020). Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group..
Anticancer Res. 34(10), 5649-55.
(2014).
(2013).
(2014). Functional aspects of the EGF-induced MAP kinase cascade: a complex self-organizing system approach..
PLoS One. 9(11), e111612.
(2014). Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw..
J Clin Oncol. 27(32), 5356-62.
(2009). Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA..
J Cancer. 11(21), 6454-6459.
(2020). Neo-adjuvant chemotherapy in early stage non-small cell lung cancer..
J Thorac Dis. 5 Suppl 4, S446-8.
(2013).
(2015).
Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families..
BMC Cancer. 10, 544.
(2010). Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring..
J Am Acad Dermatol. 82(2), 398-406.
(2020). Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2..
Anticancer Res. 32(1), 175-81.
(2012).